Variables that affect assays for plasma cytokines and soluble activation markers. - Wikidata - awgldk - TriplyDB

Variables that affect assays for plasma cytokines and soluble activation markers.

Variables that affect assays for plasma cytokines and soluble activation markers.

http://www.wikidata.org/entity/Q33997552

about

ELISA and multiplex technologies for cytokine measurement in inflammation and aging research Bioanalytical chemistry of cytokines--a review Cell surface concentrations and concentration ranges for testing in vitro autocrine loops and small molecules Nitrogen biobank for cardiovascular research.Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.Temporal reliability of cytokines and growth factors in EDTA plasma.Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons.Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen Positive affect and inflammation during radiation treatment for breast and prostate cancer.Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research Collection of aerosolized human cytokines using Teflon® filters Reproducibility of serum cytokines and growth factors The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner Relationship between acid-base status and inflammation in the critically ill.Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples.Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis.TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths Statin use and markers of immunity in the Doetinchem cohort study.Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection.Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary.Effect of storage temperatures on the stability of cytokines in cervical mucous.The role of cytokines and hot flashes in perimenopausal depression.Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study Detection of immunoglobulin isotypes from dried blood spots Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response.Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.Study design issues in evaluating immune biomarkers.Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences.Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.Cytokines as biomarkers in rheumatoid arthritis.Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies.

P2860

Q24656682-CD799955-DC09-49E2-8954-425AD1D49D84 Q26851317-CB8C02A6-C470-45F4-9C18-ECE0E51E518E Q28484638-F5D1426B-CC21-4B47-A7F3-58BB88320F30 Q30433587-9D2350EF-5143-4EFA-901B-D390E32CB411 Q33507170-6F239F9A-6F81-4073-83A0-DF06A7B07E78 Q33745785-D3D82730-CD76-460A-9717-402408B5E020 Q33847836-E7661533-08BA-49BB-BED8-9D5C3AD9998D Q33910359-8F917389-54C4-4A6A-9DC6-BAE8A062C6D1 Q33998456-9C538445-9997-46B7-86D3-C2B25C0A17C9 Q33998597-BE7640B9-48D7-48FB-8F15-52E6C146F4E4 Q34001129-A861163C-8281-4122-84CB-74E18A7538B8 Q34012459-BECFB853-CC6D-4E92-AC55-5BA7C91F460A Q34202905-7E3A8F39-20A7-4291-AA9D-0ADE8586969D Q34264527-2E732B89-833E-4620-BA58-4708FF690BCF Q34305127-2F394F57-40D3-4518-978A-D9DC3DCC66B9 Q34307377-C929068A-E52C-4313-B9ED-AEE1081FEB1D Q34468656-6E3C033E-FAC1-4507-BE35-A182B8BF17AF Q34548699-C0985FA3-AF12-4BF6-9395-AAEC7A03ACB5 Q34713720-BDC6E0A2-D951-4043-A077-17A92AD0F606 Q34995781-DAB5294B-06C6-4415-AA99-0BF75FEAB517 Q35023243-E6FB4411-AD70-42EA-9799-10C3754A88EF Q35166976-18283FBC-EE63-4F87-8C60-6DA06912B9BD Q35206877-B6021FE4-5A74-4D73-8EFE-96E0367BD627 Q35581715-E46A3482-AFA0-4A8C-BC26-856736283C41 Q35641902-007A483B-BD24-4227-BEA1-4370AD37C31B Q35904496-9E12AF1E-4981-44EC-A54E-999BD9088439 Q35933430-B0027C6D-A6B9-4914-88CC-AEC31B7B8286 Q35945930-15EF0285-2418-4302-BE58-984EF36B120F Q35953412-140C32A0-9B0B-4575-9300-C63B5DEF4A6F Q36104275-8E40F4B7-4526-490E-9D4B-1C9B120EAC59 Q36330238-4B44DB87-8F4F-4641-AD31-FE1761C211B9 Q36403297-C4453FAA-9D12-450E-892D-2AA67E628985 Q37012913-4610179D-3E9C-4242-A3B1-56DA7263A7AC Q37017101-07D73177-424F-4B67-9FD4-8D9CD0656232 Q37107494-F9DF6263-11F6-4D3F-8C66-2FD4FCE1A7C2 Q37184783-8B5742B6-3D26-4F95-840E-D8554240787D Q37207300-038E679A-C5D2-4D89-92B7-A029525B1F97 Q37592722-77E19181-1BA2-4DB9-ADA2-1FBE4B9F3284 Q37661549-C19D9731-CD6F-47C8-909C-E4E15E088F65 Q37679161-D005A365-E6DD-4D83-816B-79A2AA8FAE17

P2860

Variables that affect assays for plasma cytokines and soluble activation markers.

http://www.wikidata.org/entity/Q33997552

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Variables that affect assays for plasma cytokines and soluble activation markers.

@ast

Variables that affect assays for plasma cytokines and soluble activation markers.

@en

type

label

Variables that affect assays for plasma cytokines and soluble activation markers.

@ast

Variables that affect assays for plasma cytokines and soluble activation markers.

@en

prefLabel

Variables that affect assays for plasma cytokines and soluble activation markers.

@ast

Variables that affect assays for plasma cytokines and soluble activation markers.

@en

P1433

Q33997552-2D4A0925-2EC5-4AAE-A630-2924419B5EC1

P1476

Q33997552-06694A92-E6FD-4C9E-BCE2-A2F88DBEE1A2

P2093

Q33997552-1972EA73-FE04-4345-997B-E2DFD59A776F

Q33997552-875E3BFD-9E4B-4BC3-92BA-B2FA531EF832

Q33997552-941C0EE0-F4F4-4CBA-8A2C-8AD19896B15D

Q33997552-B2C7CB8C-5A47-40E3-BC82-291CB4DFF95F

Q33997552-D9523D6B-C9AA-4217-94D7-8AD7A7792F12

P2860

Q33997552-0DEC0F4B-13C2-4AD4-8F3B-7FEB1FB0EF70

Q33997552-0E7E3BCB-E310-417B-85B1-F902A2AA1EE5

Q33997552-17EF65C3-4D8E-4BDC-90C2-CD94ECEFD100

Q33997552-20E0A8CD-970C-4EED-B1C9-D974181C5A17

Q33997552-25551CF1-60BF-425D-B159-71AA021FECDD

Q33997552-39507867-A725-40FB-B47F-7A3C19D5231F

Q33997552-3B501258-5F57-4EEC-9824-31B40079C663

Q33997552-3F862935-BD77-4247-861A-E27E66AC1B9B

Q33997552-41803647-DABD-49EC-8EDE-B2D081258114

Q33997552-45BBD637-36F7-42D0-B974-D977C8E62CCD

P304

Q33997552-0EF8961C-83C7-48F8-AB2D-A4DEB82AFFB8

P31

Q33997552-CAA727E0-E0BA-47BF-903E-8499DFBA8552

P433

Q33997552-C3F8FE0F-B26B-4BF4-82C9-CA8C8A572762

P478

Q33997552-3FAF346D-D934-48B3-AC8B-3673CDA3CF5E

P577

Q33997552-93752C09-C1E5-4899-8952-EB3FE81C72F1

P698

Q33997552-3CE8300C-5D64-43C0-A2A6-53BB5B76B9D6

P932

Q33997552-85ECEEC6-2667-4AAA-8B03-8680922042E1

P1433

Clinical and Vaccine Immunology

P1476

Variables that affect assays for plasma cytokines and soluble activation markers.

@en

P2093

J L Fahey

http://www.w3.org/2001/XMLSchema#string

N Aziz

http://www.w3.org/2001/XMLSchema#string

P Nishanian

http://www.w3.org/2001/XMLSchema#string

R Detels

http://www.w3.org/2001/XMLSchema#string

R Mitsuyasu

http://www.w3.org/2001/XMLSchema#string

P2860

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

Cytokines--protein structure and biological activity: a complex relationship with implications for biological assays and standardization.

Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.

Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection

Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Host factors and the pathogenesis of HIV-induced disease.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. The Cytokine Consensus Study Group of the European Workshop for Rheumatology Research.

Detection and measurement of cytokines.

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

P304

89-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9874670

http://www.w3.org/2001/XMLSchema#string

P932

95666

http://www.w3.org/2001/XMLSchema#string